> Prostate Cancer & Patient Support > Patient Summits

A Patient’s Perspective

View Transcript here.

Mr. Mike Morris shares his remarkable experience of joining an early-phase clinical trial of an investigational therapy. Diagnosed with metastatic prostate cancer in 2019, he received the best therapies available, but his disease progressed. In consultation with his doctors, he enrolled in a trial of a targeted radiation medicine called Actinium-225. Today, his cancer appears dormant.